Drug Type Small molecule drug |
Synonyms Wild type Rac1 inhibitor (Revere Pharma) |
Target |
Action inhibitors |
Mechanism RAC1 inhibitors(Rac family small GTPase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | IND Application | United States | 12 Apr 2024 | |
Colorectal Cancer | Preclinical | United States | 12 Apr 2024 |